Publications in collaboration with researchers from Universidad Autónoma de Madrid (3)

2017

  1. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families

    Familial Cancer, Vol. 16, Núm. 4, pp. 567-575

2016

  1. Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial

    Journal of Neuro-Oncology, Vol. 127, Núm. 3, pp. 569-579

2012

  1. Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

    Anti-Cancer Drugs, Vol. 23, Núm. 6, pp. 659-665